Cynosure, Inc. will host an investor event in New York City on Tuesday, September 15 to introduce SculpSure™, the only FDA-cleared hyperthermic laser treatment for non-invasive fat reduction. The Company will provide a live webcast of the event presentations from approximately 10:00 a.m. to 12:30 p.m. (ET).

Cynosure Chairman and Chief Executive Officer Michael Davin, President and Chief Financial Officer Timothy Baker and Executive Vice President of Worldwide Sales Douglas Delaney will host the event. In addition, the Company is honored to have as a presenter Bruce E. Katz, MD, Director of the Cosmetic Surgery & Laser Clinic at Mount Sinai Medical Center and Director of the Juva Skin & Laser Center in New York.

The event will highlight Cynosure's proprietary hyperthermic laser technology and the global market opportunity for SculpSure as well as the Company's business model, distribution plans and marketing strategy. Dr. Katz will detail the clinical experience with SculpSure and demonstrate the treatment protocol.

The live webcast will be available on the "Investors" section of the Company's website, www.cynosure.com. For those unable to listen to the live presentations, the event will be archived and available on the Company's website for 90 days.